Initial Management of Rheumatoid Arthritis

Anna Gramling; James R. O'Dell

doi:10.1016/j.rdc.2012.05.003

Initial Management of Rheumatoid Arthritis

Anna Gramling, James R. O'Dell

Research output: Contribution to journal › Review article › peer-review

19 Scopus citations

Abstract

The prognosis for the patient with newly diagnosed rheumatoid arthritis (RA) has dramatically changed over the last two decades. If a patient is diagnosed and treated early by a rheumatologist with the goal of remission or low disease activity, half of patients can expect to achieve remission while taking their disease-modifying antirheumatic drugs. This article discusses the initial therapy in early RA and reviews the studies and trials available in the literature.

Original language	English (US)
Pages (from-to)	311-325
Number of pages	15
Journal	Rheumatic Disease Clinics of North America
Volume	38
Issue number	2
DOIs	https://doi.org/10.1016/j.rdc.2012.05.003
State	Published - May 2012

Keywords

DMARD
Disease-modifying antirheumatic drug
Rheumatoid arthritis

ASJC Scopus subject areas

Rheumatology

Access to Document

10.1016/j.rdc.2012.05.003

Cite this

@article{ef9a31b53b3d4f7495e47bbd3e689691,

title = "Initial Management of Rheumatoid Arthritis",

abstract = "The prognosis for the patient with newly diagnosed rheumatoid arthritis (RA) has dramatically changed over the last two decades. If a patient is diagnosed and treated early by a rheumatologist with the goal of remission or low disease activity, half of patients can expect to achieve remission while taking their disease-modifying antirheumatic drugs. This article discusses the initial therapy in early RA and reviews the studies and trials available in the literature.",

keywords = "DMARD, Disease-modifying antirheumatic drug, Rheumatoid arthritis",

author = "Anna Gramling and O'Dell, {James R.}",

year = "2012",

month = may,

doi = "10.1016/j.rdc.2012.05.003",

language = "English (US)",

volume = "38",

pages = "311--325",

journal = "Rheumatic Disease Clinics of North America",

issn = "0889-857X",

publisher = "W.B. Saunders",

number = "2",

}

TY - JOUR

T1 - Initial Management of Rheumatoid Arthritis

AU - Gramling, Anna

AU - O'Dell, James R.

PY - 2012/5

Y1 - 2012/5

N2 - The prognosis for the patient with newly diagnosed rheumatoid arthritis (RA) has dramatically changed over the last two decades. If a patient is diagnosed and treated early by a rheumatologist with the goal of remission or low disease activity, half of patients can expect to achieve remission while taking their disease-modifying antirheumatic drugs. This article discusses the initial therapy in early RA and reviews the studies and trials available in the literature.

AB - The prognosis for the patient with newly diagnosed rheumatoid arthritis (RA) has dramatically changed over the last two decades. If a patient is diagnosed and treated early by a rheumatologist with the goal of remission or low disease activity, half of patients can expect to achieve remission while taking their disease-modifying antirheumatic drugs. This article discusses the initial therapy in early RA and reviews the studies and trials available in the literature.

KW - DMARD

KW - Disease-modifying antirheumatic drug

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=84863997412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863997412&partnerID=8YFLogxK

U2 - 10.1016/j.rdc.2012.05.003

DO - 10.1016/j.rdc.2012.05.003

M3 - Review article

C2 - 22819086

AN - SCOPUS:84863997412

SN - 0889-857X

VL - 38

SP - 311

EP - 325

JO - Rheumatic Disease Clinics of North America

JF - Rheumatic Disease Clinics of North America

IS - 2

ER -

Initial Management of Rheumatoid Arthritis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this